Loxo Oncology Inc buy stratec
Start price
17.05.18
/
50%
€144.77
Target price
09.01.19
€171.38
Performance (%)
44.82%
End price
09.01.19
€209.65
Summary
This prediction ended on 09.01.19 with a price of €209.65. The BUY prediction by stratec for Loxo Oncology Inc saw massive gains of 44.82%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Loxo Oncology Inc | - | - | - | - |
| iShares Core DAX® | -2.195% | 0.670% | 0.546% | 51.111% |
| iShares Nasdaq 100 | -2.629% | 2.992% | 34.108% | 91.988% |
| iShares Nikkei 225® | -2.021% | 3.141% | 53.424% | 65.852% |
| iShares S&P 500 | -1.670% | 2.405% | 23.220% | 66.636% |
Comments by stratec for this prediction
In the thread Loxo Oncology Inc diskutieren
Bayer und Loxo bei Larotrectinib auf Kurs, mit einer Übernahme, die Sinn macht!
https://seekingalpha.com/news/3357468-loxo-oncology-plus-18-percent-cancer-drug-shows-promise-early-trial
https://www.deutsche-apotheker-zeitung.de/news/artikel/2018/03/26/bayer-und-loxo-bei-larotrectinib-auf-kurs
(Vom Mitglied beendet)